Talcum Powder Contact Us Mass Tort Leads For Law Firms

Talcum Powder Leads

Velawcity is a legal advertising network, that has consistently supplied law firms with high quality pre-screened talcum powder claimants. Although talcum powder is a mature claim, there are still plenty of viable claimants out there that need your help. Law firms can use our industry standard talcum powder criteria or Velawcity will run a custom campaign based on your specific criteria.

Our talcum powder packet program will include your law firm’s agreement, HIPAA & HITECH forms. Not only are potential claimants highly vetted by our call center intake specialists, but every signed packet must also pass through our stringent quality assurance process. Once this packet is delivered to your firm, the data is uploaded to your custom talcum powder campaign dashboard. Here you will see real-time campaign updates letting you know key data points like age, type of injury, year of diagnosis, stage of cancer and many more important KPI’s.

Ready For Talcum Powder Leads?

Start Your Talcum Powder Campaign Today

Velawcity provides pre-screening intake services for law firms nationwide. Our call center is located in the United States.

We remain compliant with CCPA, TCPA, CAN-SPAM and ABA Advertising and Ethical Guidelines.

Lead Generation through TV, Radio, Social Media, Google and more.
Intake Qualification involves pre-screening claimants for our law firms.
Contract Services for mass tort and class action firms nationwide.

Ovarian Cancer Claims Against Talcum Powder

The International Agency for Research on Cancer (IARC) is part of the World Health Organization (WHO) and classifies talc that contains asbestos as “carcinogenic to humans”. Based on numerous additional studies involving thousands of individuals, women who used talcum products are 30% more likely to develop ovarian cancer. This means that women who regularly use talcum-based powder as a part of their feminine hygiene routine have a significantly higher chance of developing ovarian cancer.

Talcum powder is the focus of cancer lawsuits because of its brand recognition, long use, and marketing specifically for “feminine hygiene” uses. The Shower-to-Shower® Body Powder by Johnson & Johnson® is another product developed about 50 years ago. The company continued marketing Shower-to-Shower® products despite knowing about the research on a possible connection between talcum powder and cancer. Their most popular slogan remained “a sprinkle a day keeps odor away” even when they had the research.

Other companies have also been at fault in some lawsuits, including Whittaker, Clark & Daniels® and Cashmere Boutique by Colgate-Palmolive®. However, Johnson & Johnson’s® products are more popular and have many more lawsuits filed against them.

J&J® Loses Their Bid To Have A $4.7 Billion Talcum Powder Verdict Set Aside

On December 19, 2018, Johnson & Johnson® lost their bid at having a $4.9B verdict set aside. The company failed to persuade a Missouri trial judge to set aside their verdict from July that awarded a record $4.69 billion to 22 women. Those 22 women blamed their ovarian cancer on the company’s Baby Powder and other talc products.

On July 13, 2018, the St. Louis jury awarded $550 million in compensatory damages and $4.14 billion in punitive damages.

J&J® Fails To Overturn $2.12 Billion Baby Powder Verdict, Plans Supreme Court Appeal

On November 3, 2020, Johnson & Johnson® failed to overturn a $2.12 billion baby powder verdict. Reuters reports, that the Missouri Supreme Court upheld a June 23 decision by a state appeals court, which upheld a jury’s July 2018 finding of liability but reduced J&J’s® payout from $4.69 billion after dismissing claims by some of the 22 plaintiffs. Johnson & Johnson® said it plans to appeal to the U.S. Supreme Court.

Contact Velawcity Today To Start Your Talcum Powder Cancer Campaign

What Law Firms Have To Say

References:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621109/

https://www.cancer.org/cancer/cancer-causes/talcum-powder-and-cancer.html

https://cebp.aacrjournals.org/content/25/10/1411.abstract

https://www.reuters.com/article/us-health-talc-cancer-idUSKCN0W52R1

https://www.reuters.com/article/us-johnson-johnson-cancer/jj-loses-bid-to-have-4-7-billion-talc-verdict-set-aside-vows-to-appeal-idUSKCN1OI27P

https://www.reuters.com/article/us-johnson-johnson-talc-ruling/johnson-johnson-fails-to-overturn-2-12-billion-baby-powder-verdict-plans-supreme-court-appeal-idUSKBN27J2N4